Comparing liver cancer screening methods for people with Hepatitis B
Part of Cancer, Digestive system clinical trials.
This study compares different ways to screen for liver cancer in people with chronic Hepatitis B. It is for adults living in Zhongshan City, China, who are 35 or older and have tested positive for Hepatitis B surface antigen (HBsAg). The goal is to find the best method to catch liver cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in Zhongshan City, Guangdong Province.
- You need to be at least 35 years old.
- You must have tested positive for Hepatitis B surface antigen (HBsAg), meaning you have a chronic Hepatitis B infection.
- You cannot have had liver cancer or a liver transplant in the past.
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at your risk of developing liver cancer if you have hepatitis B. It uses your medical history and test results to give you a better idea of your risk and help guide next steps.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.
This study tests a new way to find liver cancer early in people who are at higher risk, using regular ultrasound and blood tests. If you qualify, you'll get close monitoring to catch any problems sooner, which may improve treatment options.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study is testing a new way to predict if people with chronic hepatitis B, who also have liver fibrosis or cirrhosis, might develop liver cancer (HCC). It uses your medical data to create a risk score, which could help you and your doctor plan earlier and more tailored monitoring.
Hear when a new Hepatocellular Cancer (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.